Article Text

Download PDFPDF

Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation
  1. Thomas Lee Torp1,2,
  2. Ryo Kawasaki3,
  3. Tien Yin Wong4,
  4. Tunde Peto2,5,
  5. Jakob Grauslund1,2
  1. 1 Department of Ophthalmology, Odense University Hospital, Odense, Denmark
  2. 2 Department of Clinical Research, University of Southern Denmark, Odense, Denmark
  3. 3 Department of Public Health, Yamagata University Graduate School of Medical Science, Yamagata, Japan
  4. 4 Singapore National Eye Centre, Duke NUS Medical School, National University of Singapore, Singapore, Singapore
  5. 5 Department of Ophthalmology, Queen’s University Belfast, Belfast, UK
  1. Correspondence to Dr. Thomas Lee Torp, Department of Ophthalmology, Odense University Hospital, Sdr. Boulevard 29, Odense, Denmark; thomas.lee.torp{at}rsyd.dk

Abstract

Background/Aims Proliferative diabetic retinopathy (PDR) is a severe blinding condition. We investigated whether retinal metabolism, measured by retinal oximetry, may predict PDR activity after panretinal laser photocoagulation (PRP).

Methods We performed a prospective, interventional, clinical study of patients with treatment-naive PDR. Wide-field fluorescein angiography (OPTOS, Optomap) and global and focal retinal oximetry (Oxymap T1) were performed at baseline (BL), and 3 months (3M) after PRP. Angiographic findings were used to divide patients according to progression or non-progression of PDR after PRP. We evaluated differences in global and focal retinal oxygen saturation between patients with and without progression of PDR after PRP treatment.

Results We included 45 eyes of 37 patients (median age and duration of diabetes were 51.6 and 20 years). Eyes with progression of PDR developed a higher retinal venous oxygen saturation than eyes with non-progression at 3M (global: +5.9% (95% CI –1.5 to 12.9), focal: +5.4%, (95% CI –4.1 to 14.8)). Likewise, progression of PDR was associated with a lower arteriovenular (AV) oxygen difference between BL and 3M (global: –6.1%, (95% CI –13.4 to –1.4), focal: –4.5% (95% CI –12.1 to 3.2)). In a multiple logistic regression model, increment in global retinal venular oxygen saturation (OR 1.30 per 1%-point increment, p=0.017) and decrement in AV oxygen saturation difference (OR 0.72 per 1%-point increment, p=0.016) at 3M independently predicted progression of PDR.

Conclusion Development of higher retinal venular and lower AV global oxygen saturation independently predicts progression of PDR despite standard PRP and might be a potential non-invasive marker of angiogenic disease activity.

  • neovascularisation
  • treatment lasers
  • imaging

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors JG conceived the aims and overall design of the study. TLT acquired the data and did the writing of the different sections, tables and figures. JG and TLT did the literature search and statistical analyses. All authors were involved in the study design, data analyses, data interpretation and revision of the paper. The following authors had access to the full raw dataset: TLT and JG. The corresponding author had the final responsibility to submit for publication.

  • Funding The funders (the Velux Foundation and the Region of Southern Denmark) had no influence on the study design, data collection, analysis, interpretation of the data or writing of the report.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval The Regional Scientific Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost B Jonas